In conclusion, this is a pilot studyto demonstrate that compared with the preoperative condition, nodifferences in plasma concentrations of ET-1, NO, and inflammatory mediators wereobserved in DM patients after LEBS. The gene discussed is EDN1; the disease is diabetes mellitus.